Newsroom

Actions

160218 PR VI BIOSCIENCE STEMI EN

Actions

Orsiro Demonstrates Benefit over Xience in Heart Attack Subgroup

Lower Rate of Target Lesion Failure with Orsiro for ST-Segment Elevation Myocardial Infarction Patients in Randomized Controlled BIOSCIENCE Trial






Please contact us if you require further information

${loading}